Vogt Koyanagi Harada Disease
4
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Intravitreal Injection Of Bevacizumab
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
25%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)
Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment
Research Network
Common Treatments
- Intravitreal Injection Of Bevacizumab1
- Early Highdose Corticosteroid And Immunosuppressive Therapy1
- Suprachoroidal Triamcinolone Acetonide Injection For Serous Retinal Detachment In Vkh Disease1
- Suprachoroidal Triamcinolone Acetonide Injection1
- Bevacizumab1
Active Sponsors
- Benha University2
- Asociación para Evitar la Ceguera en México1
- Fundação de Amparo à Pesquisa do Estado de São Paulo1
- University of Sao Paulo1
Top Investigators
Benha University, faculty of medicine
Asociación para Evitar la Ceguera en México
University of Sao Paulo School of Medicine Ophthalmology
Benha University, faculty of medicine
Benha University, faculty of medicine
Related Conditions
- Diabetic Macular Edema1
- Multifocal Choroiditis1
- Serpiginous Choroiditis1
- Retinal Vein Occlusion1